BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/25/2023 11:20:42 AM | Browse: 144 | Download: 429
 |
Received |
|
2023-08-08 02:47 |
|
Peer-Review Started |
|
2023-08-08 02:47 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-08-24 07:08 |
|
Revised |
|
2023-08-31 15:01 |
|
Second Decision |
|
2023-09-14 02:53 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-09-14 08:16 |
|
Articles in Press |
|
2023-09-14 08:16 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-09-18 02:53 |
|
Publish the Manuscript Online |
|
2023-09-25 11:20 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Ophthalmology |
| Manuscript Type |
Randomized Controlled Trial |
| Article Title |
Randomized controlled trial on the efficacy and safety of autologous serum eye drops in dry eye syndrome
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Na Zheng and Si-Quan Zhu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Si-Quan Zhu, MD, Chief Doctor, Department of Ophthalmology, Beijing Anzhen Hospital Affiliated to China Medical University, No. 2 Anzhen Road, Chaoyang District, Beijing 100029, China. gveuhxsb@yeah.net |
| Key Words |
Autologous serum eye drops; Dry eye syndrome; Safety; Effectiveness; Alternative therapy; Conventional artificial tears |
| Core Tip |
Autologous serum eye drops (ASEDs) are safe and effective alternative therapies for managing moderate-to-severe dry eye syndrome (DES). The study comparing ASEDs to conventional artificial tears found that ASEDs significantly improved the ocular surface disease index score, tear break-up time, Schirmer I test, corneal fluorescein staining, and conjunctival impression cytology over 12 wk. The ASEDs group showed greater improvement in these measures than the artificial tears group. Moreover, no severe adverse events were reported, indicating the safety of the ASEDs. These findings suggest that ASEDs are a valuable treatment option for patients with DES who respond poorly to traditional therapies. |
| Publish Date |
2023-09-25 11:20 |
| Citation |
Zheng N, Zhu SQ. Randomized controlled trial on the efficacy and safety of autologous serum eye drops in dry eye syndrome. World J Clin Cases 2023; 11(28): 6774-6781 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i28/6774.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i28.6774 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
